Corpus Luteum Deficiency (CLD)

Corpus Luteum Deficiency (CLD) is a condition in which the corpus luteum produces insufficient progesterone to adequately support the endometrium for implantation and early pregnancy maintenance. CLD names the anatomical source of the deficit: the corpus luteum itself is underperforming. This distinguishes it from Luteal Phase Deficiency (LPD), which describes the hormonal pattern. CLD is the structural cause; LPD is the measurable consequence. A clinician can observe LPD on a progesterone profile without identifying CLD as the origin, and treat downstream without correcting upstream.

The clinical significance of CLD in infertile populations is frequently missed by standard workup. In one cohort of infertile couples undergoing RRM evaluation, 0% had been diagnosed with corpus luteum deficiency prior to their RRM assessment. After comprehensive cycle-timed evaluation, 71% received the diagnosis.1 Standard infertility workups use a single mid-luteal progesterone draw. That single number is insufficient to characterize corpus luteum function. The corpus luteum produces progesterone in a pulsatile pattern across the luteal phase. A single measurement can look normal while the integrated progesterone output across the phase is inadequate.

NaProTechnology identifies CLD through multiple cycle-timed progesterone measurements across the post-Peak phase rather than a single draw. A flat, declining, or consistently low progesterone curve identifies corpus luteum failure specifically.2 Treatment addresses both the luteal phase directly and, when indicated, the follicular phase that preceded it: corpus luteum quality depends heavily on follicular development. A follicle that was small, grew slowly, or ruptured prematurely produces a suboptimal corpus luteum. Optimizing follicle development before ovulation is part of the upstream correction. Post-ovulation support is timed to the cycle chart via Peak-plus series monitoring rather than a calendar estimate.

CLD is a common finding in couples with unexplained infertility and in women with early pregnancy loss. The role of the hCG signal from the early embryo in rescuing and extending corpus luteum function adds another layer to the diagnostic picture: if the embryo's hCG output is insufficient, the corpus luteum may fail even when its own capacity is intact. Evaluating both sides of the corpus luteum-embryo signaling axis is an RRM diagnostic priority in couples with early loss.

Cited in this entry

  1. Boyle P, Toth A, Minjeur M, Turczynski C. Restorative reproductive medicine (RRM) outcomes compared to in-vitro fertilization (IVF) for the treatment of infertility: a retrospective evaluation of a 2019 clinic cohort. Journal of Restorative Reproductive Medicine. https://rrmacademy.org/library/restorative-reproductive-medicine-rrm-outcomes-compared-to-in-vitro-fertilization-rec4qqhafqb8stlnd/
  2. Jones GS. The luteal phase defect. Fertility and Sterility. https://rrmacademy.org/library/the-luteal-phase-defect-recgxbtnrrbujvgmj/

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.